[HTML][HTML] E3 ubiquitin ligases: styles, structures and functions

Q Yang, J Zhao, D Chen, Y Wang - Molecular biomedicine, 2021 - Springer
E3 ubiquitin ligases are a large family of enzymes that join in a three-enzyme ubiquitination
cascade together with ubiquitin activating enzyme E1 and ubiquitin conjugating enzyme E2 …

[HTML][HTML] Emerging role of ubiquitination in the regulation of PD-1/PD-L1 in cancer immunotherapy

X Hu, J Wang, M Chu, Y Liu, Z Wang, X Zhu - Molecular Therapy, 2021 - cell.com
A growing amount of evidence suggests that ubiquitination and deubiquitination of
programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) play crucial roles in the …

[HTML][HTML] ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

X Xiao, J Shi, C He, X Bu, Y Sun, M Gao… - Nature …, 2023 - nature.com
The programmed cell death protein 1 (PD-1) is an inhibitory receptor on T cells and plays an
important role in promoting cancer immune evasion. While ubiquitin E3 ligases regulating …

[HTML][HTML] The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy

B Hou, T Chen, H Zhang, J Li, P Wang… - Frontiers in …, 2023 - frontiersin.org
The tumor microenvironment (TME) is the tumor surrounding environment, which is critical
for tumor development and progression. TME is also involved in clinical intervention and …

[HTML][HTML] Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease

NV Arinze, W Yin, S Lotfollahzadeh… - The Journal of …, 2022 - Am Soc Clin Investig
Chronic kidney disease (CKD) imposes a strong and independent risk for peripheral artery
disease (PAD). While solutes retained in CKD patients (uremic solutes) inflict vascular …

[HTML][HTML] Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2

Z Wu, Z Cao, H Yao, X Yan, W Xu, M Zhang, Z Jiao… - Cell Reports, 2023 - cell.com
Posttranslational modifications represent a key step in modulating programmed death-1 (PD-
1) functions, but the underlying mechanisms remain incompletely defined. Here, we report …

Post-translational regulations of PD-L1 and PD-1: Mechanisms and opportunities for combined immunotherapy

X Dai, Y Gao, W Wei - Seminars in cancer biology, 2022 - Elsevier
Antibodies targeting programmed cell death protein 1 (PD-1) or its ligand programmed
death-ligand 1 (PD-L1) are profoundly changing the methods to treat cancers with long-term …

[HTML][HTML] Targeting ubiquitin signaling for cancer immunotherapy

X Zhou, SC Sun - Signal transduction and targeted therapy, 2021 - nature.com
Cancer immunotherapy has become an attractive approach of cancer treatment with
tremendous success in treating various advanced malignancies. The development and …

[HTML][HTML] Potential of E3 ubiquitin ligases in cancer immunity: opportunities and challenges

P Ye, X Chi, JH Cha, S Luo, G Yang, X Yan, WH Yang - Cells, 2021 - mdpi.com
Cancer immunotherapies, including immune checkpoint inhibitors and immune pathway–
targeted therapies, are promising clinical strategies for treating cancer. However, drug …

[HTML][HTML] PD-1/PD-L1 axis in organ fibrosis

Y Zhao, Y Qu, C Hao, W Yao - Frontiers in immunology, 2023 - frontiersin.org
Fibrosis is a pathological tissue repair activity in which many myofibroblasts are activated
and extracellular matrix are excessively accumulated, leading to the formation of permanent …